Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status (Q34414233)

2 August 2017

Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Martin Tenniswood

6

0 references

author name string

Sarah Mordan-McCombs

1

1 reference

2 August 2017

Theodore Brown

2

1 reference

2 August 2017

Wei-Lin Winnie Wang

3

1 reference

2 August 2017

Ann-Christin Gaupel

4

1 reference

2 August 2017

Joellen Welsh

5

1 reference

2 August 2017

27 March 2010

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

2 August 2017

1 reference

2 August 2017

121

1 reference

2 August 2017

1-2

1 reference

2 August 2017

368-371

1 reference

Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Altered VDR-mediated transcriptional activity in prostate cancer stroma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Vitamin D and androgen regulation of prostatic growth

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211603

A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice

27 October 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer

1 reference

PubMed

12 December 2020

Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate

1 reference

PubMed

12 December 2020

10.1016/J.JSBMB.2010.03.062

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference